FDA Adverse Event Malfunction Summary report: N

RELION PEN NEEDLE

MDR report key: 11914347 · Received June 1, 2021

Report

Report Number
3014704491-2021-00015
Event Type
Malfunction
Date Received
June 1, 2021
Date of Event
May 4, 2021
Report Date
June 21, 2021
Manufacturer
BECTON DICKINSON MEDICAL DEVICES CO., LTD. SUZHOU
Product Code
FMI
PMA / PMN Number
K162516
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION: CUSTOMER RETURNED (22) SEALED 32GX4MM PEN NEEDLES FROM LOT# 0140357. THE CUSTOMER REPORTED THAT THE PEN NEEDLES ARE SHORTER. ALL 22 RETURNED SAMPLES WERE EXAMINED, THEN TESTED TO DETERMINE PATIENT END CANNULA LENGTH (SPECS FOR 4MM CANNULA LENGTH: 0.109¿-0.203¿). ALL OBSERVATIONS MEASURED WITHIN SPECIFICATION. NO DEFECTS WERE OBSERVED. DHR WAS REVIEWED FOR LOT#0140357 AND NO QN FOUND. BD WAS NOT ABLE TO DUPLICATE OR CONFIRM THE CUSTOMER¿S INDICATED FAILURE ROOT CAUSE CANNOT BE DETERMINED AT THIS TIME AS THE ISSUE IS UNCONFIRMED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE RELION® PEN NEEDLE LENGTH WAS SHORTER THAN NORMAL. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CONSUMER LEFT VOICEMAIL STATING THAT THE PEN NEEDLES ARE SHORTER."

Additional Manufacturer Narrative · 1

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE RELION® PEN NEEDLE LENGTH WAS SHORTER THAN NORMAL. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CONSUMER LEFT VOICEMAIL STATING THAT THE PEN NEEDLES ARE SHORTER."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
812123 RELION PEN NEEDLE HYPODERMIC SINGLE LUMEN NEEDLE FMI BECTON DICKINSON MEDICAL DEVICES CO., LTD. SUZHOU 0140357

Patients

Seq Age Sex Outcome Treatment
1